Wellington Management Group LLP Bio N Tech Se Transaction History

Wellington Management Group LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $21.8 Million - $32.9 Million	-176,515 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $3,913 - $7,187	-31 Reduced 0.02%	176,515 $30.1 Million
Q4 2021 Feb 11, 2022	BUY	$216.64 - $362.52 $38.2 Million - $64 Million	176,546 New	176,546 $45.5 Million
Q2 2021 Aug 16, 2021	SELL	$113.32 - $241.49 $41.5 Million - $88.4 Million	-366,030 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $2.86 Million - $3.99 Million	-33,362 Reduced 8.35%	366,030 $40 Million
Q4 2020 Feb 12, 2021	SELL	$72.71 - $129.54 $12.7 Million - $22.7 Million	-174,912 Reduced 30.46%	399,392 $32.6 Million
Q3 2020 Nov 16, 2020	SELL	$57.81 - $104.17 $1.32 Million - $2.39 Million	-22,908 Reduced 3.84%	574,304 $39.8 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $23 Million - $39.9 Million	597,212 New	597,212 $39.9 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.